Stocks / Pharmaceuticals
NEOGPharmaceuticals
Neogen Corp
$12.941d +2.6%5d +9.9%settled close · 2026-09-17
Mkt cap $2.0B (3/25)β 1.3352w $8.19–12.94Shares 217.5MInd. In Vitro & In Vivo Diagnostic SubstancesNasdaq since 1989Emp. 1,456HQ Lansing, MIneogen.com
Who’s talkingIdea Scout · free
Who’s talking about NEOG
No tracked investor commentary on NEOG yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 7 Oct 2026
Confirmed date · consensus EPS -0.07. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where NEOG’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 8 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-17 | ||||||
| 2026-09-16 | ||||||
| 2026-08-19 | ||||||
| 2026-07-31 | ||||||
| 2026-07-30 | ||||||
| 2026-07-01 | ||||||
| 2026-06-10 | ||||||
| 2026-06-08 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
NEOG is in this morning’s Brief.
Get The Brief — $20/mo →